Roche seeks more time for Avastin in breast cancer (Reuters)
Reuters – Swiss drugmaker Roche Holding argued for more time to study the effect of its Avastin medicine for breast cancer as U. S. health advisers prepared to vote on the fate of the treatment.
View full post on Yahoo! News: Health News
Leave a Reply